Trials / Completed
CompletedNCT02853188
Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of Lung
Does the Measure of the Plasma Tissue Factor Allow to Predict a Venous Thromboembolism Episode for Patients Presenting a Primitive Lung Cancer?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 315 (actual)
- Sponsor
- Hopital Foch · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate if the plasma activity of the tissue factor at the time of the diagnosis of a lung cancer, before any treatment, or after the treatment of induction (surgery or two first cures of chemotherapy), can be a predictive factor of venous thromboembolism disease in the year which follows the diagnosis, independently of the other parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | venous thromboembolism |
Timeline
- Start date
- 2014-12-04
- Primary completion
- 2018-12-20
- Completion
- 2018-12-20
- First posted
- 2016-08-02
- Last updated
- 2019-08-15
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02853188. Inclusion in this directory is not an endorsement.